SenesTech, Inc. (SNES) Stock Analysis

Company Overview

SenesTech, Inc. is a specialized entity focused on the development and commercialization of technologies designed to manage animal pest populations specifically through fertility control mechanisms. The company operates within the Basic Materials sector and more specifically within the Specialty Chemicals industry, positioning itself as a provider of chemical solutions for agricultural or pest management challenges. The organization currently maintains a market capitalization of $8.86M and employs a workforce of 23 individuals, generating total annual revenue of $2.22M over the trailing twelve months. These figures indicate that SenesTech operates on a micro-cap scale with limited revenue generation, suggesting a nascent or highly niche market position where the company is likely still in a phase of scaling operations or product commercialization rather than mature market dominance.

Financial Health

The company reported revenue of $2.22M for the trailing twelve months, yet it simultaneously recorded a net income loss of $-6,383,000 and an EBITDA of $-6,370,000, revealing a severe disconnect between top-line activity and bottom-line profitability. This significant gap between revenue and net income highlights a cost structure that is not yet covered by operational earnings, indicating high burn rates or substantial one-time costs that have not been offset by gross margins. The firm generated free cash flow of $-3,711,375, which signifies a negative cash position that limits immediate financial flexibility and necessitates external capital injection to sustain operations. Despite these operational losses, the company holds a cash balance of $8.57M against total debt of $2.68M, resulting in a debt-to-equity ratio of 27.98 which suggests a leveraged balance sheet relative to equity but provides a substantial liquidity buffer. The current ratio stands at 12.61, a metric that indicates exceptionally strong short-term liquidity, suggesting the company possesses ample current assets to cover its short-term obligations. Furthermore, the return on equity is -105.7% and the return on assets is -50.4%, metrics that reveal that management has not yet achieved positive returns on the capital deployed by shareholders or the total asset base.

Valuation Assessment

SenesTech presents a trailing P/E ratio of N/A and a forward P/E of -0.37, a disparity that implies earnings are currently negative and that any forward earnings projection relies on assumptions regarding future profitability rather than historical performance. The price-to-book ratio is recorded at 0.91, indicating that the market values the company at slightly less than its book value, which often occurs when investors discount the value of intangible assets or expect ongoing operational challenges. Alternative valuation metrics such as the price-to-sales ratio of 3.99 and an EV/EBITDA of -0.47 suggest that the stock is being priced based on revenue multiples rather than earnings power, reflecting the high risk associated with unprofitable growth companies. The 52-week high for the stock is $6.24 while the 52-week low is $1.30, placing the current valuation context within a range of over fourfold expansion from the low, though the exact current price percentage requires specific spot data not provided in the summary. The beta value is 0.15, which indicates that the stock exhibits very low volatility relative to the broader market and moves with minimal sensitivity to general market swings.

Growth & Income

Revenue growth year-over-year is listed at -16.0%, while earnings growth year-over-year is N/A due to the lack of comparable prior period earnings data to establish a positive growth trajectory. Since the company is currently unprofitable with negative net income, there are no dividend payouts, resulting in a dividend yield of N/A and a payout ratio of 0.0%, which means the company reinvests all available resources into operations rather than distributing income to shareholders. The absence of dividend payments combined with negative revenue growth suggests the company is in a survival or early-stage development mode where capital retention is prioritized over income generation for investors. The overall growth and income profile is characterized by declining revenue and negative earnings, indicating that the business is currently expanding its market share or refining its technology at the expense of immediate financial performance.